Predictors of urgent complications of peptic ulcer
https://doi.org/10.21518/ms2023-132
Abstract
Introduction. In recent decades, there has been a decrease in the prevalence of peptic ulcer (PU), but this trend does not correlate with the frequency of bleeding and mortality from PU: the disease remains the main cause of bleeding with a high mortality rate.
Aim. To study the predictors of urgent complications of PU, using endoscopic, laboratory and clinical signs of gastric bleeding.
Materials and methods. Observational cross-sectional (one-stage) study of 181 hospital patients diagnosed with ulcerative disease (84 men, 97 women), mean age 53 ± 27.6 (18–89) years. The stratification of endoscopic characteristics of ulcerative defects of the mucous membrane of the stomach and duodenum (DU) was carried out according to the Clinical guidelines “Diagnosis and treatment of PU in adults (2020)”, bleeding assessment – according to the Forrest classification (1974), selection of patients’ age by periods: 18–35 years (young age); 36–59 years (average age); 60–74 years old (old age); 75–89 years old (old age).
Results. The results of studies have shown that the potential for ulcer bleeding is increased in the presence of the following factors. An increase in the patient’s age (the proportion of middle age is 44.2%, the elderly – 35.4%) and male gender. Duration of ulcer history (46.9%), H. pylori-positivity (74.6%); comorbidities requiring anticoagulants, antiplatelet agents and non-steroidal anti-inflammatory drugs (NSAIDs) (70.1%), the presence of two or more risk factors (20.4%).
Conclusion. Not only predictors of urgent complications of PU have been established, but also a dissonance indicating a high frequency of occult bleeding in the disease. The frequency of laboratory symptoms of anemia – 55.8%; endoscopic signs – 19.3%, including stigmata of a high risk of rebleeding – 14.3%; clinical symptoms of gastric blood loss – 14.4%. The risk of complications and mortality is associated with both frequent latent course and escalation of NSAID consumption.
About the Authors
O. V. Shtygasheva
Katanov Khakass State University
Russian Federation
Russian Federation
Olga V. Shtygasheva, Dr. Sci. (Med.), Professor, Professor of the Department of Internal Medicine
655000, 92, Lenin Ave., Abakan
E. S. Ageeva
Vernadsky Crimean Federal University
Russian Federation
Russian Federation
Elizaveta S. Ageeva, Dr. Sci. (Med.), Associate Professor, Head of the Department of Medical Biology
295051, 5/2, Lenin Boulevard, Simferopol
References
1. Chan F.K.L., Lau J.Y.W. Peptic ulcer disease. In: Feldman M., Friedman L., Brandt L. (eds.). Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 10th ed. Philadelphia: Saunders Elsevier; 2015. Chapter 53.
2. Holster I.L., Kuipers E.J. Management of acute nonvariceal upper gastrointestinal bleeding: current policies and future perspectives. World J Gastroenterol. 2012;18(11):1202–1207. https://doi.org/10.3748/wjg.v18.i11.1202.
3. Gralnek I.M., Dumonceau J.M., Kuipers E.J., Lanas A., Sanders D.S., Kurien M. et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47(10):a1–46. https://doi.org/10.1055/s-0034-1393172.
4. Brullet E., Garcia-Iglesias P., Calvet X., Papo M., Planella M., Pardo A. et al. Endoscopist’s Judgment Is as Useful as Risk Scores for Predicting Outcome in Peptic Ulcer Bleeding: A Multicenter Study. J Clin Med. 2020;9(2):408. https://doi.org/10.3390/jcm9020408.
5. Wilkins T., Wheeler B., Carpenter M. Upper Gastrointestinal Bleeding in Adults: Evaluation and Management. Am Fam Physician. 2020;101(5):294–300. Available at: https://www.aafp.org/pubs/afp/issues/2020/0301/p294.html.
6. Mullady D.K., Wang A.Y., Waschke K.A. AGA Clinical Practice Update on Endoscopic Therapies for Non-Variceal Upper Gastrointestinal Bleeding: Expert Review. Gastroenterology. 2020;159(3):1120–1128. https://doi.org/10.1053/j.gastro.2020.05.095.
7. Barkun A.N., Almadi M., Kuipers E.J., Laine L., Sung J., Tse F. et al. Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group. Ann Intern Med. 2019;171(11):805–822. https://doi.org/10.7326/M19-1795.
8. Barkun A.N., Adam V., Lu Y., Chen Y.I., Martel M. Using Hemospray Improves the Cost-effectiveness Ratio in the Management of Upper Gastrointestinal Nonvariceal Bleeding. J Clin Gastroenterol. 2018;52(1):36–44. https://doi.org/10.1097/MCG.0000000000000709.
9. Van Leerdam M.E. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22(2):209–224. https://doi.org/10.1016/j.bpg.2007.10.011.
10. Bystrov S.A., Katorkin S.E., Lichman L.A., Lisin O.E. Comparison of prediction scales of recurrent ulcer gastroduodenal bleeding in hospital. Medical News of North Caucasus. 2018;13(1):41–44. (In Russ.) https://doi.org/10.14300/mnnc.2018.13012.
11. Hawkey C.I., Wight N.J. NSAIDs and gastrointestinal complications. In: LSC Life Science Communications. Lоndon; 2001, pp. 1–56.
12. May A., Hahn E.G. Ulkus und Erosionen durch Medikamente. In: Hahn E.G., Riemann J.F. (eds.). Klinische Gastroenterologie. Stuttgart, New York: Thieme Verlag; 2000. Vol. 1, pp. 756–762.
13. Lanza F.L., Chan F.K., Quigley E.M. Guidelines for prevention of NSAIDrelated ulcer complications. Am J Gastroenterol. 2009;104(3):728–738. https://doi.org/10.1038/ajg.2009.115.
14. Lai Y., Xu Y., Zhu Z., Pan X., Long S., Liao W. et al. Development and validation of a model to predict rebleeding within three days after endoscopic hemostasis for high-risk peptic ulcer bleeding. BMC Gastroenterol. 2022;22(1):64. https://doi.org/10.1186/s12876-022-02145-9.
15. Ivashkin V.T., Sheptulin A.A., Mayev I.V., Baranskaya Yu.K., Trukhmanov A.S., Lapina T.L. et al. Diagnostics and treatment of peptic ulcer: clinical guidelines of the Russian gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(6):40–54. (In Russ.) Available at: https://www.gastro-j.ru/jour/article/view/95.
16. Ivashkin V.T., Maev I.V., Tsarkov P.V., Korolev M.P., Andreev D.N., Baranskaya E.K. et al. Diagnosis and treatment of peptic ulcer in adults (clinical guidelines of the Russian Gastroenterological Association, Russian Society of Colorectal Surgeons and the Russian Endoscopic Society). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(1):49–70. (In Russ.) https://doi.org/10.22416/1382-4376-2020-30-1-49-70.
17. Malfertheiner P., Megraud F., O’Morain C.A., Atherton J., Axon A.T., Bazzoli F. et al. Management of Helicobacter pylori infection – the Maastricht IV / Florence Consensus Report. Gut. 2012;61(5):646–664. https://doi.org/10.1136/gutjnl-2012-302084.
18. Kim M.S., Choi J., Shin W.C. AIMS65 scoring system is comparable to Glasgow-Blatchford score or Rockall score for prediction of clinical outcomes for non-variceal upper gastrointestinal bleeding. BMC Gastroenterol. 2019;19(1):136. https://doi.org/10.1186/s12876-019-1051-8.
19. Stanley A.J., Laine L., Dalton H.R., Ngu J.H., Schultz M., Abazi R. et al. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ. 2017;356:i6432. https://doi.org/10.1136/bmj.i6432.
20. Maev I.V., Samsonov A.A., Andreev N.G., Andreev D.N. Important practical results and current trends in the study of diseases of the stomach and duodenum. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2012;22(4):17–26. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=18226544.
21. Lu X., Zhang X., Chen H. Comparison of the AIMS65 score with the GlasgowBlatchford and Rockall scoring systems for the prediction of the risk of in-hospital death among patients with upper gastrointestinal bleeding. Rev Esp Enferm Dig. 2020;112(6):467–473. https://doi.org/10.17235/reed.2020.6496/2019.
22. Dong Z., Wang J., Zhan T., Zhang H., Yi L., Xu S. A New Scoring System to Predict Poor Clinical Outcomes in Acute Nonvariceal Upper Gastrointestinal Bleeding Patients with High-Risk Stigmata. Gastroenterol Res Pract. 2018:5032657. https://doi.org/10.1155/2018/5032657.
23. Valeev M.V., Timerbulatov Sh.V. Risk factors for rebleeding in patients with peptic ulcer bleeding. Kazan Medical Journal. 2020;101(3):435–440. (In Russ.) https://doi.org/10.17816/KMJ2020-435.
24. Saveliev V.S. (ed.). Guidelines for emergency surgery of the abdominal cavity. Moscow: Triada-X; 2005. 640 p. (In Russ.)
25. Wuerth B.A., Rockey D.C. Changing Epidemiology of Upper Gastrointestinal Hemorrhage in the Last Decade: A Nationwide Analysis. Dig Dis Sci. 2018;63(5):1286–1293. https://doi.org/10.1007/s10620-017-4882-6.
26. Savides T.J., Jensen D.M. Therapeutic endoscopy for nonvariceal gastrointestinal bleeding. Gastroenterol Clin North Am. 2000;29(2):465–487. https://doi.org/10.1016/s0889-8553(05)70123-0.
27. Targownik L.E., Nabalamba A. Trends in management and outcomes of acute nonvariceal upper gastrointestinal bleeding: 1993–2003. Clin Gastroenterol Hepatol. 2006;4(12):1459–1466. https://doi.org/10.1016/j.cgh.2006.08.018.
28. Lebedev N.V., Klimov A.E., Sokolova P.Yu. Prognosing the gastroduodenal ulcer bleeding recurrence. Pirogov Russian Journal of Surgery. 2012;(12):77–80. (In Russ.) Available at: https://www.mediasphera.ru/issues/khirurgiyazhurnal-im-n-i-pirogova/2012/12/030023-120720121215.
29. Maev I.V., Tsukanov V.V., Tretyakova O.V., Kasparov E.V., Kucheryavyi Yu.A., Andreev N.G., Vasyutin A.V. Therapeutic aspects of the treatment of ulcerative bleeding. Farmateka. 2012;2:56–59. (In Russ.) Available at: https://pharmateca.ru/ru/archive/article/8349.
30. Jiménez Rosales R., Martínez-Cara J.G., Vadillo-Calles F., Ortega-Suazo E.J., Abellán-Alfocea P., Redondo-Cerezo E. Analysis of rebleeding in cases of an upper gastrointestinal bleed in a single center series. Rev Esp Enferm Dig. 2019;111(3):189–192. https://doi.org/10.17235/reed.2018.5702/2018.
Review
For citations:
Shtygasheva OV, Ageeva ES. Predictors of urgent complications of peptic ulcer. Meditsinskiy sovet = Medical Council. 2023;(8):28-32. (In Russ.) https://doi.org/10.21518/ms2023-132
Views:
426
Email this article 